Inaia Phoenix, Ph.D.
Instructor of Microbiology and Immunology
Evans Center, room #318
Inaia Phoenix, Ph.D. is a teaching fellow of Microbiology and Immunology at Marian University School of Osteopathic Medicine. Dr. Phoenix earned a B.S. in zoology from Southeastern Oklahoma University in Durant, OK. Then, she earned her Ph.D. in Experimental Pathology at the University of Texas - Medical Branch (UTMB) in Galveston, TX. Her dissertation project focused on vaccine development for Rift Valley fever virus, a zoonotic pathogen endemic to Africa and Select Agent. Dr. Phoenix researched the adaptive immune response to Vaccinia virus, the virus used to vaccinate against smallpox, during her post-doctoral training at The Brody School of Medicine at East Carolina University in Greenville, NC.
Dr. Phoenix's extensive background includes a diverse repertoire of sciences including microbiology, immunology, genetics, zoology, conservation, and veterinary medicine. While working as the Public Outreach Intern for the United States Fish & Wildlife Service and Science, she was responsible for developing various educational outreach programs and coordinating the Umbagog Wildlife Festival. She also worked as a Science Education Instructor for the JOLT (Journey on Lake Texoma) Program at the All Saints Camp Conference Center in Pottsboro, TX. The JOLT program is an outdoor science program based on the STARR and TEKS guidelines for K-12 student. She also worked as a veterinary nurse for two years prior to going to graduate school.
Her research interests include zoonotic pathogens, viruses, vaccine development, and molecular virology.
Phoenix I, Lokugamage N, Nishiyama S, Ikegami T. 2016. Mutational Analysis of the Rift Valley fever virus Glycoprotein Precursor Proteins for Gn Protein Expression. Viruses. 8, 151. doi: 10.3390/v8060151.
Phoenix I, Nishiyama S, Lokugamage N, Hill TE, Huante M, Slack O, Carpio V, Freiberg AN, Ikegami T. 2016. N-glycans on the Rift Valley fever virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN. Viruses. 8, 149. doi: 10.3390/v8050149.
Phoenix I, Ikegami T. Pathogenesis of Rift Valley fever in humans. 2015. Pathogenesis of Rift Valley fever virus in Humans. In Singh, S.K. (Ed), Emerging and Re-emerging Human Infections (pp. 73-92). John Wiley & Sons/Wiley Blackwell Press.
Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B, Head JA, Tigabu B, Smith JK, Zhang L, Juelich TL, Gong B, Freiberg AN, Ikegami T. 2013. Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains the neuroinvasiveness in mice. J.Gen.Virol. 94: 1441-50.